JENNIFER KIM: Open Payments
NPI 1598314254 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 56 payments from 25 companies in 2025. Trend: 2023 $2,497 · 2024 $2,304 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $272 |
| Biogen, Inc. | 6 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| GENZYME CORPORATION | 2 | $67 |
| JAZZ PHARMACEUTICALS INC. | 2 | $63 |
| Lundbeck LLC | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $60 |
| Neurelis, Inc. | 3 | $60 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
Products named: QULIPTA, TYSABRI, UBRELVY, REXULTI, HYQVIA, EPIDIOLEX, VALTOCO, FYCOMPA.
Industry payments across GA — which companies pay providers there.
